787 Poster Presentation Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma Marnix L. Bosch, MBA, PhD; Linda Liau; Keyoumars Ashkan; Completed Clinical Trials Antigen presenting cells; Clinical trial; Dendritic cell; Vaccine
Poster Presentation Dates All odd numbered posters will be presented on Wednesday, Nov. 11, from 5:15-5:45 p.m. EST and Friday, Nov. 13, from 4:40-5:10 p.m. EST.
Posters will be on display from 8 a.m. on Monday, Nov. 9, until the virtual poster hall closes on December 31, 2020.